The generic prescription drug memantine is also available as brand-name Namenda. It comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine is prescribed ...

In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate receptor ...

Migraine disease is a complex neurological condition with so many variations that there’s no single treatment that’s safe or effective for everyone. That’s why, despite all the recent advances in ...

Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of ...

A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is ...

Please provide your email address to receive an email when new articles are posted on . There are no FDA-approved medications for post-traumatic headache. Most patients reported treatment had a ...

In a disappointing turn for Down's syndrome (DS) research, a trial to evaluate potential cognitive benefits of the drug memantine—already used as a treatment in Alzheimer's disease—showed no ...

† Adverse events occurring in at least 2% of patients treated with memantine ER and at a rate that is higher than in the placebo group. SIB: significant benefit for memantine (LSMD: 2.6; 95% CI: 1.0–4 ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...